Lv11
90 积分 2023-04-11 加入
Precision Therapy of Recurrent Breast Cancer through Targeting Different Malignant Tumor Cells with a HER2/CD44‐Targeted Hydrogel Nanobot
2小时前
待确认
Targeted therapies in HER2-positive breast cancer with receptor-redirected Arazyme-linker-Herceptin as a novel fusion protein
2小时前
已完结
Modulation of the Tumor Immune Microenvironment by Bi2Te3‐Au/Pd‐Based Theranostic Nanocatalysts Enables Efficient Cancer Therapy
6个月前
已完结
Tumor Microenvironment-Activable Manganese-Boosted Catalytic Immunotherapy Combined with PD-1 Checkpoint Blockade
6个月前
已完结
Cucumber‐Derived Extracellular Vesicle‐Functionalized Metal‐Organic Frameworks for Enhanced Photodynamic Therapy of Hypertrophic Scars
7个月前
已完结
Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets
8个月前
已完结
A phase Ib study of abemaciclib in combination with pembrolizumab for patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or metastatic breast cancer (MBC) (NCT02779751): Interim results
1年前
已关闭
Novel endocrine therapies: What is next in estrogen receptor positive, HER2 negative breast cancer?
1年前
已完结
Selective Estrogen receptor degraders (SERDs) for the treatment of breast cancer: An overview
1年前
已完结
Pharmacology and pharmacokinetics of elacestrant
1年前
已完结
皖公网安备34019202002308
